{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T12:08:10Z","timestamp":1785499690455,"version":"3.56.0"},"reference-count":48,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8,1]]},"abstract":"<jats:p>Intracranial hemorrhage in a term neonate is a rare event in the absence of an identifiable precipitating factor such as severe thrombocytopenia, mechanical trauma, asphyxia, infections, or congenital vascular malformations. Congenital disorders of glycosylation are a genetically and clinically heterogeneous group of multisystem disorders characterized by the abnormal glycosylation of a number of glycoproteins. Although bleeding caused by abnormal glycosylation of various coagulation factors is a well-known clinical complication of several types of congenital disorders of glycosylation, intracranial hemorrhage has not been reported as an initial manifestation of this entity. Here we report the detailed history of a family with 2 consecutive male infants, both born at term with intracranial hemorrhage diagnosed within the first 24 hours of life. The diagnosis of a congenital disorder of glycosylation was established in the second infant by an abnormal glycosylation of serum transferrin detected by electrospray-ionization mass spectrometry. Both infants showed significant neurologic deterioration during the first month of life, and both died at 5 months of age. Intracranial hemorrhage in a term neonate without a potential precipitating factor represents yet another clinical feature that should raise the suspicion for a congenital disorder of glycosylation.<\/jats:p>","DOI":"10.1542\/peds.2005-1307","type":"journal-article","created":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:57:13Z","timestamp":1151715433000},"page":"e514-e521","source":"Crossref","is-referenced-by-count":14,"title":["Intracranial Hemorrhage as the Initial Manifestation of a Congenital Disorder of Glycosylation"],"prefix":"10.1542","volume":"118","author":[{"given":"Ronald D.","family":"Cohn","sequence":"first","affiliation":[{"name":"McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Eklund","sequence":"additional","affiliation":[{"name":"Glycobiology and Carbohydrate Chemistry Program, Burnham Institute for Medical Research, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda L.","family":"Bergner","sequence":"additional","affiliation":[{"name":"McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F.","family":"Casella","sequence":"additional","affiliation":[{"name":"Divisions of Hematology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Lee","family":"Woods","sequence":"additional","affiliation":[{"name":"Neonatology, Department of Pediatrics"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janyne","family":"Althaus","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin J.","family":"Blakemore","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold E.","family":"Fox","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Hoover-Fong","sequence":"additional","affiliation":[{"name":"McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ada","family":"Hamosh","sequence":"additional","affiliation":[{"name":"McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Braverman","sequence":"additional","affiliation":[{"name":"McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hudson H.","family":"Freeze","sequence":"additional","affiliation":[{"name":"Glycobiology and Carbohydrate Chemistry Program, Burnham Institute for Medical Research, La Jolla, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeon A.","family":"Boyadjiev","sequence":"additional","affiliation":[{"name":"McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2006,8,1]]},"reference":[{"key":"2021120822374277800_R1","doi-asserted-by":"crossref","unstructured":"Jaeken J, Carchon H. Congenital disorders of glycosylation: a booming chapter of pediatrics. Curr Opin Pediatr.\u20082004;16:434\u2013943","DOI":"10.1097\/01.mop.0000133636.56790.4a"},{"key":"2021120822374277800_R2","unstructured":"Freeze HH. Genetic defects in the human glycome. Nat Rev Genet. In press"},{"key":"2021120822374277800_R3","doi-asserted-by":"crossref","unstructured":"Grunewald S, Matthijs G, Jaeken J. Congenital disorders of glycosylation: a review. Pediatr Res.\u20082002;52:618\u2013624","DOI":"10.1203\/00006450-200211000-00003"},{"key":"2021120822374277800_R4","doi-asserted-by":"crossref","unstructured":"Jaeken J, van Eijk HG, van der Heul C, Corbeel L, Eeckels R, Eggermont E. Sialic acid-deficient serum and cerebrospinal fluid transferrin in a newly recognized genetic syndrome. Clin Chim Acta.\u20081984;144:245\u2013247","DOI":"10.1016\/0009-8981(84)90059-7"},{"key":"2021120822374277800_R5","doi-asserted-by":"crossref","unstructured":"Lacey JM, Bergen HR, Magera MJ, Naylor S, O'Brien JF. Rapid determination of transferrin isoforms by immunoaffinity liquid chromatography and electrospray mass spectrometry. Clin Chem.\u20082001;47:513\u2013518","DOI":"10.1093\/clinchem\/47.3.513"},{"key":"2021120822374277800_R6","doi-asserted-by":"crossref","unstructured":"Cohn RD. Dystroglycan: important player in muscle and beyond [published correction appears in Neuromusc Disord. 2005;15:573]. Neuromusc Disord.\u20082005;15:207\u2013217","DOI":"10.1016\/j.nmd.2004.11.005"},{"key":"2021120822374277800_R7","doi-asserted-by":"crossref","unstructured":"Muntoni F, Voit T. The congenital muscular dystrophies in 2004: a century of exciting progress. Neuromusc Disord.\u20082004;14:635\u2013649","DOI":"10.1016\/j.nmd.2004.06.009"},{"key":"2021120822374277800_R8","doi-asserted-by":"crossref","unstructured":"Quentin E, Gladen A, Roden L, Kresse H. A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci USA.\u20081990;87:1342\u20131346","DOI":"10.1073\/pnas.87.4.1342"},{"key":"2021120822374277800_R9","doi-asserted-by":"crossref","unstructured":"Kitagawa H, Shimakawa H, Sugahara K. The tumor suppressor EXT-like gene EXTL2 encodes an alpha1, 4-N-acetylhexosaminyltransferase that transfers N-acetylgalactosamine and N-acetylglucosamine to the common glycosaminoglycan-protein linkage region: the key enzyme for the chain initiation of heparan sulfate. J Biol Chem.\u20081999;274:13933\u201313937","DOI":"10.1074\/jbc.274.20.13933"},{"key":"2021120822374277800_R10","doi-asserted-by":"crossref","unstructured":"Kim S, Westphal V, Srikrishna G, et al. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie). J Clin Invest.\u20082000;105:191\u2013198","DOI":"10.1172\/JCI7302"},{"key":"2021120822374277800_R11","doi-asserted-by":"crossref","unstructured":"Eklund EA, Newell JW, Sun L, et al. Molecular and clinical description of the first US patients with congenital disorder of glycosylation Ig. Mol Genet Metab.\u20082005;84:25\u201331","DOI":"10.1016\/j.ymgme.2004.09.014"},{"key":"2021120822374277800_R12","doi-asserted-by":"crossref","unstructured":"Whitby EH, Griffiths PD, Rutter S, et al. Frequency and natural history of subdural haemorrhages in babies and relation to obstetric factors. Lancet.\u20082004;363:846\u2013851","DOI":"10.1016\/S0140-6736(04)15730-9"},{"key":"2021120822374277800_R13","doi-asserted-by":"crossref","unstructured":"Towner D, Castro MA, Eby-Wilkens E, Gilbert WM. Effect of mode of delivery in nulliparous women on neonatal intracranial injury. N Engl J Med.\u20081999;341:1709\u20131714","DOI":"10.1056\/NEJM199912023412301"},{"key":"2021120822374277800_R14","doi-asserted-by":"crossref","unstructured":"Lee KN, Tae WC, Jackson KW, Kwon SH, McKee PA. Characterization of wild-type and mutant alpha2-antiplasmins: fibrinolysis enhancement by reactive site mutant. Blood.\u20081999;94:164\u2013171","DOI":"10.1182\/blood.V94.1.164.413k16_164_171"},{"key":"2021120822374277800_R15","doi-asserted-by":"crossref","unstructured":"Anwar R, Minford A, Gallivan L, Trinh CH, Markham AF. Delayed umbilical bleeding: a presenting feature for factor XIII deficiency\u2014clinical features, genetics, and management. Pediatrics.\u20082002;109(2). Available at: www.pediatrics.org\/cgi\/content\/full\/109\/2\/e32","DOI":"10.1542\/peds.109.2.e32"},{"key":"2021120822374277800_R16","doi-asserted-by":"crossref","unstructured":"Van Geet C, Jaeken J. A unique pattern of coagulation abnormalities in carbohydrate-deficient glycoprotein syndrome. Pediatr Res.\u20081993;33:540\u2013541","DOI":"10.1203\/00006450-199305000-00024"},{"key":"2021120822374277800_R17","doi-asserted-by":"crossref","unstructured":"Van Geet C, Jaeken J, Freson K, et al. Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications. J Inherit Metab Dis.\u20082001;24:477\u2013492","DOI":"10.1023\/A:1010581613821"},{"key":"2021120822374277800_R18","doi-asserted-by":"crossref","unstructured":"Jaeken J, Vanderschueren-Lodeweyckx M, Casaer P, et al. Familial psychomotor retardation with markedly fluctuating serum proteins, FSH and GH levels, partial TBG-deficiency, increased serum arylsulphatase A and increased CSF protein: a new syndrome?Pediatr Res.\u20081980;14:179","DOI":"10.1203\/00006450-198002000-00117"},{"key":"2021120822374277800_R19","doi-asserted-by":"crossref","unstructured":"Imtiaz F, Worthington V, Champion M, et al. Genotypes and phenotypes of patients in the UK with carbohydrate-deficient glycoprotein syndrome type 1. J Inherit Metab Dis.\u20082000;23:162\u2013174","DOI":"10.1023\/A:1005669900330"},{"key":"2021120822374277800_R20","doi-asserted-by":"crossref","unstructured":"Matthijs G, Schollen E, Pardon E, et al. Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet.\u20081997;16:88\u201392","DOI":"10.1038\/ng0597-88"},{"key":"2021120822374277800_R21","doi-asserted-by":"crossref","unstructured":"Van Schaftingen E, Jaeken J. Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I. FEBS Lett.\u20081995;377:318\u2013320","DOI":"10.1016\/0014-5793(95)01357-1"},{"key":"2021120822374277800_R22","doi-asserted-by":"crossref","unstructured":"Niehues R, Hasilik M, Alton G, et al. Carbohydrate-deficient glycoprotein syndrome type Ib: phosphomannose isomerase deficiency and mannose therapy. J Clin Invest.\u20081998;101:1414\u20131420","DOI":"10.1172\/JCI2350"},{"key":"2021120822374277800_R23","doi-asserted-by":"crossref","unstructured":"de Koning TJ, Dorland L, van Diggelen OP, et al. A novel disorder of N-glycosylation due to phosphomannose isomerase deficiency. Biochem Biophys Res Commun.\u20081998;245:38\u201342","DOI":"10.1006\/bbrc.1998.8385"},{"key":"2021120822374277800_R24","doi-asserted-by":"crossref","unstructured":"Westphal V, Peterson S, Patterson M, et al. Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia. Genet Med.\u20082001;3:393\u2013398","DOI":"10.1097\/00125817-200111000-00003"},{"key":"2021120822374277800_R25","doi-asserted-by":"crossref","unstructured":"Westphal V, Kjaergaard S, Davis JA, Peterson SM, Skovby F, Freeze HH. Genetic and metabolic analysis of the first adult with congenital disorder of glycosylation type Ib: long-term outcome and effects of mannose supplementation. Mol Genet Metab.\u20082001;73:77\u201385","DOI":"10.1006\/mgme.2001.3161"},{"key":"2021120822374277800_R26","doi-asserted-by":"crossref","unstructured":"Damen G, de Klerk H, Huijmans J, den Hollander J, Sinaasappel M. Gastrointestinal and other clinical manifestations in 17 children with congenital disorders of glycosylation type Ia, Ib, and Ic. J Pediatr Gastroenterol Nutr.\u20082004;38:282\u2013287","DOI":"10.1097\/00005176-200403000-00010"},{"key":"2021120822374277800_R27","doi-asserted-by":"crossref","unstructured":"Ko\u0308rner C, Knauer R, Stephani U, Marquardt T, Lehle L, von Figura K. Carbohydrate deficient glycoprotein syndrome type IV: deficiency of dolichyl-P-Man:Man5GlcNAc2-PP-dolichyl mannosyltransferase. EMBO J.\u20081999;18:6816\u20136822","DOI":"10.1093\/emboj\/18.23.6816"},{"key":"2021120822374277800_R28","doi-asserted-by":"crossref","unstructured":"Stibler H, Stephani U, Kutsch U. Carbohydrate-deficient glycoprotein syndrome: a fourth subtype. Neuropediatrics.\u20081995;26:235\u2013237","DOI":"10.1055\/s-2007-979762"},{"key":"2021120822374277800_R29","doi-asserted-by":"crossref","unstructured":"Imbach T, Schenk B, Schollen E, et al. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J Clin Invest.\u20082000;105:233\u2013239","DOI":"10.1172\/JCI8691"},{"key":"2021120822374277800_R30","doi-asserted-by":"crossref","unstructured":"Schenk B, Imbach T, Frank CG, et al. MPDU1 mutations underlie a novel human congenital disorder of glycosylation, designated type If [published correction appears in J Clin Invest. 2003;111:925]. J Clin Invest.\u20082001;108:1687\u20131695","DOI":"10.1172\/JCI200113419"},{"key":"2021120822374277800_R31","doi-asserted-by":"crossref","unstructured":"Kranz C, Denecke J, Lehrman MA, et al. A mutation in the human MPDU1 gene causes congenital disorder of glycosylation type If (CDG-If). J Clin Invest.\u20082001;108:1613\u20131619","DOI":"10.1172\/JCI13635"},{"key":"2021120822374277800_R32","doi-asserted-by":"crossref","unstructured":"Chantret I, Dupre T, Delenda C, et al. Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem.\u20082002;277:25815\u201325822","DOI":"10.1074\/jbc.M203285200"},{"key":"2021120822374277800_R33","doi-asserted-by":"crossref","unstructured":"Grubenmann CE, Frank CG, Kjaergaard S, Berger EG, Aebi M, Hennet T. ALG12 mannosyltransferase defect in congenital disorder of glycosylation type lg. Hum Mol Genet.\u20082002;11:2331\u20132339","DOI":"10.1093\/hmg\/11.19.2331"},{"key":"2021120822374277800_R34","doi-asserted-by":"crossref","unstructured":"Chantret I, Dancourt J, Dupre T, et al. A deficiency in dolichyl-P-glucose:Glc1Man9GlcNAc2-PP-dolichyl alpha3-glucosyltransferase defines a new subtype of congenital disorders of glycosylation. J Biol Chem.\u20082003;278:9962\u20139971","DOI":"10.1074\/jbc.M211950200"},{"key":"2021120822374277800_R35","doi-asserted-by":"crossref","unstructured":"Schollen E, Frank CG, Keldermans L, et al. Clinical and molecular features of three patients with congenital disorders of glycosylation type Ih (CDG-Ih) (ALG8 deficiency). J Med Genet.\u20082004;41:550\u2013556","DOI":"10.1136\/jmg.2003.016923"},{"key":"2021120822374277800_R36","doi-asserted-by":"crossref","unstructured":"Thiel C, Schwarz M, Peng J, et al. A new type of congenital disorders of glycosylation (CDG-Ii) provides new insights into the early steps of dolichol-linked oligosaccharide biosynthesis. J Biol Chem.\u20082003;278:22498\u201322505","DOI":"10.1074\/jbc.M302850200"},{"key":"2021120822374277800_R37","doi-asserted-by":"crossref","unstructured":"Wu X, Rush JS, Karaoglu D, et al. Deficiency of UDP-GlcNAc:dolichol phosphate N-acetylglucosamine-1 phosphate transferase (DPAGT1) causes a novel congenital disorder of glycosylation type Ij. Hum Mutat.\u20082003;22:144\u2013150","DOI":"10.1002\/humu.10239"},{"key":"2021120822374277800_R38","doi-asserted-by":"crossref","unstructured":"Grubenmann CE, Frank CG, Hu\u0308lsmeier AJ, et al. Deficiency of the first mannosylation step in the N-glycosylation pathway causes congenital disorder of glycosylation type Ik. Hum Mol Genet.\u20082004;13:535\u2013542","DOI":"10.1093\/hmg\/ddh050"},{"key":"2021120822374277800_R39","doi-asserted-by":"crossref","unstructured":"Kranz C, Denecke J, Lehle L, et al. Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of mannosyltransferase I. Am J Hum Genet.\u20082004;74:545\u2013551","DOI":"10.1086\/382493"},{"key":"2021120822374277800_R40","doi-asserted-by":"crossref","unstructured":"Schwarz M, Thiel C, Lu\u0308bbehusen J, et al. Deficiency of GDP-Man: GLcNAc2-PP-dolichol mannosyltransferase causes congenital disorder of glycosylation type Ik. Am J Hum Genet.\u20082004;74:472\u2013481","DOI":"10.1086\/382492"},{"key":"2021120822374277800_R41","doi-asserted-by":"crossref","unstructured":"Frank CG, Grubenmann CE, Eyaid W, Berger EG, Aebi M, Hennet T. Identification and functional analysis of a defect in the human ALG9 gene: definition of congenital disorder of glycosylation type IL. Am J Hum Genet.\u20082004;75:146\u2013150","DOI":"10.1086\/422367"},{"key":"2021120822374277800_R42","doi-asserted-by":"crossref","unstructured":"Ramaekers VT, Stibler H, Kint J, Jaeken J. A new variant of the carbohydrate deficient glycoproteins syndrome. J Inherit Metab Dis.\u20081991;14:385\u2013388","DOI":"10.1007\/BF01811710"},{"key":"2021120822374277800_R43","doi-asserted-by":"crossref","unstructured":"Etzioni A, Frydman M, Pollack S, et al. Recurrent severe infections caused by a novel leukocyte adhesion deficiency. N Engl J Med.\u20081992;327:1789\u20131792","DOI":"10.1056\/NEJM199212173272505"},{"key":"2021120822374277800_R44","doi-asserted-by":"crossref","unstructured":"Marquardt T, Brune T, Luhn K, et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism. J Pediatr.\u20081999;134:681\u2013688","DOI":"10.1016\/S0022-3476(99)70281-7"},{"key":"2021120822374277800_R45","doi-asserted-by":"crossref","unstructured":"De Praeter CM, Gerwig GJ, Bause E, et al. A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency. Am J Hum Genet.\u20082000;66:1744\u20131756","DOI":"10.1086\/302948"},{"key":"2021120822374277800_R46","doi-asserted-by":"crossref","unstructured":"Hansske B, Thiel C, Lubke T, et al. Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. J Clin Invest.\u20082002;109:725\u2013733","DOI":"10.1172\/JCI0214010"},{"key":"2021120822374277800_R47","doi-asserted-by":"crossref","unstructured":"Wu X, Steet RA, Bohorov O, et al. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder. Nat Med.\u20082004;10:518\u2013523","DOI":"10.1038\/nm1041"},{"key":"2021120822374277800_R48","doi-asserted-by":"crossref","unstructured":"Martinez-Duncker I, Dupre T, Piller V, et al. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. Blood.\u20082005;105:2671\u20132676","DOI":"10.1182\/blood-2004-09-3509"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e514\/1073546\/zpe0080600e514.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/118\/2\/e514\/1073546\/zpe0080600e514.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T02:21:37Z","timestamp":1639016497000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/118\/2\/e514\/68935\/Intracranial-Hemorrhage-as-the-Initial"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8,1]]},"references-count":48,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2006,8,1]]},"published-print":{"date-parts":[[2006,8,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2005-1307","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8,1]]}}}